News

$4.2 Billion to Acquire Edwards’ Hemodynamic Monitoring Products
(press release)

FACTS about Edwards' hemodynamic products:

• $928M total sales in 2023 
• ​7% yearly sales growth (5-year CAGR)  ​
• Core product: Swan-Ganz PA catheters *
• ​Acquired by BD for $4.2 Billion in June 2024

* Large stiff catheters filled with liquid using external electro-mechanical sensors, 50-year-old technology. INVASIVE, RISKY and IMPRECISE